BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribeiro-santos R, de Campos-carli SM, Ferretjans R, Teixeira-carvalho A, Martins-filho OA, Teixeira AL, Salgado JV. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment. Nordic Journal of Psychiatry 2020;74:187-93. [DOI: 10.1080/08039488.2019.1688389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chumakov E, Dorofeikova M, Tsyrenova K, Petrova N. A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia. Front Psychiatry 2022;13:943869. [PMID: 35873262 DOI: 10.3389/fpsyt.2022.943869] [Reference Citation Analysis]
2 Huang Z, Kang M, Li G, Xiong P, Chen H, Kang L, Li S, Lu C, Li Q, Bai M. Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia. Journal of Psychiatric Research 2022;151:539-45. [DOI: 10.1016/j.jpsychires.2022.05.004] [Reference Citation Analysis]
3 Morrens M, Overloop C, Coppens V, Loots E, Van Den Noortgate M, Vandenameele S, Leboyer M, De Picker L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol Psychiatry 2022. [PMID: 35484245 DOI: 10.1038/s41380-022-01582-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Soloveva K, Volkova M, Alekseeva P, Andryshchenko A, Kostyuk G, Gurina O, Chekhonin V. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Int J Mol Sci 2022;23:1217. [PMID: 35163141 DOI: 10.3390/ijms23031217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Dias ICS, de Campos-Carli SM, Vieira ELM, Mota APL, Azevedo PS, Anício VTDS, Guimarães FC, Mantovani LM, Cruz BF, Teixeira AL, Salgado JV. Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia. J Psychiatr Res 2021:S0022-3956(21)00669-5. [PMID: 34785039 DOI: 10.1016/j.jpsychires.2021.11.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Martínez AL, Brea J, Rico S, de Los Frailes MT, Loza MI. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments. Int J Mol Sci 2021;22:9905. [PMID: 34576069 DOI: 10.3390/ijms22189905] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Markiewicz R, Markiewicz-Gospodarek A, Dobrowolska B, Łoza B. Improving Clinical, Cognitive, and Psychosocial Dysfunctions in Patients with Schizophrenia: A Neurofeedback Randomized Control Trial. Neural Plast 2021;2021:4488664. [PMID: 34434228 DOI: 10.1155/2021/4488664] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 King S, Holleran L, Mothersill D, Patlola S, Rokita K, McManus R, Keynon M, McDonald C, Hallahan B, Corvin A, Morris D, Kelly J, McKernan D, Donohoe G. Early Life Adversity, Functional Connectivity And Cognitive Performance In Schizophrenia: The Mediating Role Of IL-6. Brain Behav Immun 2021:S0889-1591(21)00247-6. [PMID: 34242739 DOI: 10.1016/j.bbi.2021.06.016] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Pontifex MG, Malik MMAH, Connell E, Müller M, Vauzour D. Citrus Polyphenols in Brain Health and Disease: Current Perspectives. Front Neurosci 2021;15:640648. [PMID: 33679318 DOI: 10.3389/fnins.2021.640648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Miller BJ, Goldsmith DR. Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder. Focus (Am Psychiatr Publ) 2020;18:391-401. [PMID: 33343251 DOI: 10.1176/appi.focus.20200015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ansari-Lari M, Zendehboodi Z, Masoudian M, Mohammadi F. Additive effect of glutathione S-transferase T1 active genotype and infection with Toxoplasma gondii for increasing the risk of schizophrenia. Nord J Psychiatry 2021;75:275-80. [PMID: 33191823 DOI: 10.1080/08039488.2020.1843711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]